Boehringer Ingelheim gets FDA approval for 2 drugs

... While more than 15 million Americans have been diagnosed with COPD, Boehringer Ingelheim, which has offices in Danbury and Ridgefield, estimates that 45 percent of the cases in the United States remain undiagnosed until lung function is ...

via http://ift.tt/1FGiwCb